MobileMedMinder: A Networked Aide for Medication Compliances

The main aim of this study is to conduct a randomized control trial to compare MobileMedMinder, a mobile phone based medication reminder software product, with currently accepted and empirically supported methods for increasing medication compliance through reminders and tracking.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure, Congestive Cardiovascular Diseases Heart Diseases Heart Failure

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Maryland

Baltimore, Maryland, 21201, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.

Exclusion criteria

Inability to understand informed consent
Inability to read and understand English

Treatment and study plan

Use of MobileMedMinder

Behavioral

Use of an intervention to remind patients to take their medications.

Primary outcomes

Compliance

Time frame: 3 months

Pill counts will be used to assess compliance

Sponsors and collaborators

Lead sponsor

University of Maryland, Baltimore

Other

Collaborators

Limaging

Registry information

Important dates

Study start: 2011
Primary completion: 2013
Study completion: 2013
First posted: May 14, 2012
Registry last updated: Mar 9, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed